Macrophage Migration Inhibitory Factor-2
D-DTproteinMIF-2 promotes plaque inflammation and atherosclerosis via chemokine and lipogenic signaling.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleAtypical chemokine driving atherosclerosis and plaque inflammation; ischemia-reperfusion mediator.
Also acts inLipid entry/oxidation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- An atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis.Nature communications · 2025 · PMID 40055309 · doi
- MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.Expert opinion on therapeutic targets · 2017 · PMID 28562118 · doi